William White
Director of Finance/CFO at AKERO THERAPEUTICS, INC.
Net worth: 880 757 $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jonathan Young | M | 54 | 7 years | |
| John Quisel | M | 52 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 4 years |
| Kevin Bitterman | M | 47 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 7 years |
| Joanne Bryce | F | 57 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 7 years |
| Georges Gemayel | M | 63 | 3 years | |
| Raju Mohan | M | 67 | 6 years | |
| Mark Iwicki | M | 57 | 6 years | |
| William Savage | M | 50 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 4 years |
| Andrew Cheng | M | 57 | 6 years | |
| Mark Chin | M | 42 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 3 years |
| Liam Ratcliffe | M | 60 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 5 years |
| Mona Ashiya | M | 55 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 3 years |
| Donald Nicholson | M | 67 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 5 years |
| Jean Franchi | F | 57 | - | |
| Gary Reiner | M | 69 | 11 years | |
| Tomas Jan Heyman | M | 68 | 4 years | |
| Judy Chou | M | 58 | 3 years | |
| Graham Walmsley | M | 37 | 6 years | |
| Mike Whitaker | M | 60 | 15 years | |
| Yuan Xu | M | 56 | 3 years | |
| Yen Wen Yu | M | - | 4 years | |
| Timothy Rolph | M | 70 | 7 years | |
| Onaiza Cadoret-Manier | F | 60 | 1 years | |
| Allison Hulme | M | 61 | 1 years | |
| Diana Taylor | F | 69 | 15 years | |
| Seth Harrison | M | 63 | 7 years | |
| Ellen Costello | F | 69 | 8 years | |
| Peter Henry | M | 54 | 9 years | |
| Duncan Hennes | M | 67 | 11 years | |
| Jane Henderson | F | 58 | 5 years | |
| James Turley | M | 68 | 11 years | |
| Renée James | F | 60 | 8 years | |
| Jay Backstrom | M | 69 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 3 years |
| Somu Subramaniam | M | 69 | 6 years | |
| Christina Tartaglia | F | - | - | |
| Jennifer Lowney | F | - | 10 years | |
| Rahul Khara | M | - | - | |
| Srikanth Venkatraman | M | - |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 7 years |
| James Goldberg | M | - | 14 years | |
| John J. Schembri | M | 62 | 5 years | |
| Libette Luce | F | - | 2 years | |
| William Joseph Mills | M | 68 | 12 years | |
| Pamela Stephenson | F | 56 | - | |
| Martin Auster | M | 49 | 3 years | |
| Kitty Yale | F | 52 | 6 years | |
| Thomas Rogers | M | - | 8 years | |
| Preston Horner | M | - | 9 years | |
| Eric M. Snyder | M | - |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | - |
| Arindam Bose | M | 71 | 5 years | |
| Eric Jetter | M | - | 11 years | |
| John Nuss | M | 65 | 5 years | |
| Edward Skyler | M | 50 | 14 years | |
| Bainiaksina Julija | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian MacDonald | M | - |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | - |
| Aaron Royston | M | 40 | 4 years | |
| Daniel Callahan | M | 67 | 11 years | |
| John Paul Havens | M | 67 | 5 years | |
| Trang-Thu Tran | F | - | 6 years | |
| Ellen Alemany | F | 68 | 20 years | |
| Lisa Maria Caputo | F | 60 | 6 years | |
| Patrick Curtin | M | - | - | |
| Michael O'Neill | M | 77 | 10 years | |
| Ned J. Kelly | M | 70 | 6 years | |
| Michael Corbat | M | 63 | 9 years | |
| Lyndon Olson | M | 77 | 18 years | |
| John Andrews | M | - | - | |
| Phil Bussey | M | - | 4 years | |
| Cynthia Hallenbeck | F | 67 | 6 years | |
| Keith Rohland | M | 56 | 4 years | |
| Michael Shambon | M | - | 2 years | |
| Erik L. Hall | M | - | 13 years | |
| Matthew R Melton | M | - | 2 years | |
| George Tierney | M | - | 13 years | |
| Heather Cox | F | 53 | 2 years | |
| James von Moltke | M | 55 | 8 years | |
| Lee Smallwood | M | - | 6 years | |
| Eliza Oshana McGrath | F | - | 4 years | |
| Elizabeth Fogarty | F | - | 8 years | |
| Yolande Piazza | M | 55 | 11 years | |
| William Sandborn | M | 61 | 1 years | |
| Timothy Collins | M | 67 | - | |
| William Samuel Thompson | M | 78 | 8 years | |
| Lawrence R. Ricciardi | M | 82 | 5 years | |
| Judith Rodin | M | 79 | 13 years | |
| Todd Thomson | M | 63 | 9 years | |
| Manuel Medina-Mora Escalante | M | 73 | - | |
| Jerry A. Grundhofer | M | 79 | 2 years | |
| Joan Edelman Spero | M | 79 | 5 years | |
| Robert L. Ryan | M | 80 | 8 years | |
| Vikram Pandit | M | 67 | 5 years | |
| Deborah Wright | F | 66 | 5 years | |
| Rohan Seneka Weerasinghe | M | 73 | 9 years | |
| Charles O. Prince | M | 74 | 24 years | |
| Alexander Rijn Wynaendts | M | 63 | 5 years | |
| Anthony Santomero | M | 78 | 10 years | |
| Michael Klein | M | 60 | 5 years | |
| Sheng Man Zhang | M | 66 | 10 years | |
| Martin Lippert | M | 64 | 1 years | |
| Richard Parsons | M | 76 | 16 years | |
| Peter L. Sheeran | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William White
- Personal Network
